Renalytix shares soar 32% after two-year kidneyintelX data brings revenue prospects back in view
Renalytix Plc surged at the open in London on Tuesday after the company released two-year real-world data on kidneyintelX.dkd. Still, turnover told a different story: while volume spiked, the cash value traded stayed low by institutional standards. Shares jumped 31.58% to 2.50 pence at 9:41 a.m. BST, after closing at 1.90p. Google Finance put volume at 2.53 million shares, way above the 295,790 average—about 8.6 times normal. At 2.50p, that’s about £63,000 traded, roughly 0.6% of the 437.02 million shares out.